Dermatofibroma natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2]

Overview

Dermatofibroma usually develops in the third decade of life, and most of them are asymptomatic. Common complications of dermatofibroma are related to excisional removing of the lesion and include, bleeding, infection and scar. Prognosis is generally excellent. Although, in very rare cases metastases are seen.

Natural History, Complications, and Prognosis

Dermatofibroma usually develops in the third decade of life, and most of them are asymptomatic.^[1]^[2]^[3]

Common complications of dermatofibroma are related to excisional removing of the lesion and include:^[4]
- Bleeding
- Infection
- Scar

Prognosis is generally excellent. Although, in very rare cases metastases are seen.^[5]

References

↑ Agarwal, Atin; Gopinath, Arun; Tetzlaff, Michael T.; Prieto, Victor G. (2017). “Phosphohistone-H3 and Ki67”. The American Journal of Dermatopathology. 39 (7): 504–507. doi:10.1097/DAD.0000000000000690. ISSN 0193-1091.
↑ Buehler, Darya; Weisman, Paul (2017). “Soft Tissue Tumors of Uncertain Histogenesis”. Clinics in Laboratory Medicine. 37 (3): 647–671. doi:10.1016/j.cll.2017.06.005. ISSN 0272-2712.
↑ Han, Tae Young; Chang, Hee Sun; Lee, June Hyun Kyung; Lee, Won-Mi; Son, Sook-Ja (2011). “A Clinical and Histopathological Study of 122 Cases of Dermatofibroma (Benign Fibrous Histiocytoma)”. Annals of Dermatology. 23 (2): 185. doi:10.5021/ad.2011.23.2.185. ISSN 1013-9087.
↑ David J.. Myers & Eric P.. Fillman (2019). “Dermatofibroma”. PMID 29262213.
↑ Romano, Ryan C.; Fritchie, Karen J. (2017). “Fibrohistiocytic Tumors”. Clinics in Laboratory Medicine. 37 (3): 603–631. doi:10.1016/j.cll.2017.05.007. ISSN 0272-2712.

Overview